Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Upside Biotechnologies logo — Creating advanced regenerative solutions for severe burns wi...

Upside Biotechnologies

Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling.

Founded 2016 Series A Total: $2.30M Biotechnology, Health and Wellness +1

General Information

Company Name Upside Biotechnologies
Founded Year 2016
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Upside Biotechnologies. To contact Upside Biotechnologies, visit upside.nz.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Upside Biotechnologies compare?

A PDF of Upside Biotechnologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Upside Biotechnologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Upside Biotechnologies

Upside Biotechnologies is a company that focuses on creating advanced regenerative solutions for severe burns. The company's slogan, "Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling," encapsulates their mission. Founded in 2016, Upside is at the forefront of developing the most effective treatment for severe burns. Their product offers a regenerative medicine solution by utilizing a small sample of healthy patient skin, which is then grown into differentiated, graftable skin to cover the burns. Notably, the advantages of Upside's engineered skin include faster production compared to any competitor's product, larger sheet sizes, and excellent handling characteristics. Upside Biotechnologies operates in the industries of Biotechnology, Health and Wellness, and Pharmaceutical. In 21 March 2017, the company received a NZD2.30M Series A investment from a consortium of investors, including Icehouse Ventures, Ice Angels, Tuhua Fund, New Zealand Venture Investment Fund, Cure Kids Ventures, and University of Auckland Inventors Fund. This investment signifies the confidence that prominent venture capital firms have in Upside's innovative approach to addressing the limitations of current severe burns treatments. Additionally, Upside holds intellectual property rights over the processes that provide these specific benefits, positioning the company as a key player in the regenerative medicine space.

Business keywords: Regenerative Medicine, Severe Burns, Skin Grafting, Advanced Medical Solutions, Intellectual Property, Medical Innovation, Tissue Engineering, Regenerative Solutions, Burn Treatment, Medical Technology, Skin Regeneration, Bioengineering, Medical Research, Healthcare Innovations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A NZD2.30M 6
Icehouse Ventures Ice Angels Tuhua Fund
Icehouse Ventures, Ice Angels +4
21 Mar 2017

Upside Biotechnologies Alternatives & Competitors

View All Alternatives
Upside Biotechnologies vs
Cell Tissue Technology Sdn Bhd
Cell Tissue Technology Sdn Bhd Malaysia

Empowering Medical Innovation

Venture round
19 employees
Biotechnology, Pharmaceutical
Upside Biotechnologies vs
Cartilage Inc.
Cartilage Inc. United States

Real engineered cartilage for real healing.

Grant
12 employees
Biotechnology, Health Care
Upside Biotechnologies vs
Cellestetix
Cellestetix

CX is Ready for Retail

Seed
Biotechnology, Health and Wellness
View all alternatives

FAQ About Upside Biotechnologies

Creating advanced regenerative solutions for severe burns with faster production, larger sheets, and superior handling.
Upside Biotechnologies was founded in 2016.
Upside Biotechnologies operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on Regenerative Medicine, Severe Burns, Skin Grafting and Advanced Medical Solutions.
Upside Biotechnologies has completed 1 funding round, raising a total of $2.30M. The latest funding stage is Series A.
Top alternatives and competitors to Upside Biotechnologies include Cell Tissue Technology Sdn Bhd, Cartilage Inc., Cellestetix, Orthocell Ltd, Novo Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Upside Biotechnologies and Cell Tissue Technology Sdn Bhd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Upside Biotechnologies, https://bouncewatch.com/company/upside-biotechnologies, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout